muvon_therapeutics_logo_white_10062020_1
publicvoting1.png
  • Home

  • Technology

  • Clinical Applications

  • About Us

  • News

  • Open Positions

  • Contact

  • More...

    Use tab to navigate through the menu items.
    • ALL POSTS
    • PUBLICATIONS
    • AWARDS
    • NEWS
    • INSIGHTS
    • MEDIA
    Search
    Joint statement by the leading patient group WFIPP and MUVON Therapeutics AG
    Muvon
    • Jul 19
    • 1 min

    Joint statement by the leading patient group WFIPP and MUVON Therapeutics AG

    Today, the World Federation of Incontinence and Pelvic Problems (WFIPP) released a statement of partnership and collaboration with...
    49 views0 comments
    MUVON Therapeutics is supported by the Lichtsteiner Foundation
    Muvon
    • Apr 21
    • 1 min

    MUVON Therapeutics is supported by the Lichtsteiner Foundation

    MUVON Therapeutics was selected by the Lichtsteiner Foundation to become a part of their supported community of pioneering innovators....
    85 views0 comments
    MUVON's CEO Deana Mohr featured in Top 30 In Vivo's Rising Leaders 2022
    Muvon
    • Apr 19
    • 1 min

    MUVON's CEO Deana Mohr featured in Top 30 In Vivo's Rising Leaders 2022

    MUVON Therapeutics, a spin-off from the University of Zurich developing a platform technology for the regeneration of skeletal muscle...
    162 views0 comments
    CEO Deana Mohr presented MUVON in interview for BioInnovation Spotlight
    Muvon
    • Feb 10
    • 1 min

    CEO Deana Mohr presented MUVON in interview for BioInnovation Spotlight

    Our CEO Deana Mohr had the great opportunity to present MUVONs vision and innovative regenerative cell therapy in an interview for...
    99 views0 comments
    Translation and automation hurdles for cell therapies
    Muvon
    • Jan 27
    • 1 min

    Translation and automation hurdles for cell therapies

    Informative article published in BioInsights, written by our CSO Jenny Prange and our innovation manager Beatrix Rauch Schmid. This...
    105 views0 comments
    MUVON wins second place at IFAS Innovation Challenge 2021
    Muvon
    • Sep 27, 2021
    • 1 min

    MUVON wins second place at IFAS Innovation Challenge 2021

    MUVON Therapeutics was selected as one of twelve finalists for 2021's IFAS Innovation Challenge and placed second in the final pitching...
    86 views0 comments
    Deana Mohr wins spot in Venture Leaders Medtech 2021
    Muvon
    • Jun 10, 2021
    • 1 min

    Deana Mohr wins spot in Venture Leaders Medtech 2021

    MUVON Therapeutics CEO Deana Mohr was selected as one of ten Venture Leaders in Medtech to represent the Swiss National Startup Team in...
    163 views0 comments
    MUVON featured by Startupticker
    Muvon
    • Jun 2, 2021
    • 1 min

    MUVON featured by Startupticker

    MUVON was featured in an article by Startupticker describing our regenerative approach for the treatment of incontinence and the progress...
    49 views0 comments
    MUVON Therapeutics selected as finalist for the 2021 >>venture>> Startup Competition
    Muvon
    • Apr 29, 2021
    • 1 min

    MUVON Therapeutics selected as finalist for the 2021 >>venture>> Startup Competition

    MUVON is excited to have been selected as one of the top 10 startups in the Health and Nutrition vertical of the 2021 >>venture>> startup...
    73 views0 comments
    MUVON Therapeutics selected for Tech4Eva accelerator program
    Muvon
    • Apr 21, 2021
    • 1 min

    MUVON Therapeutics selected for Tech4Eva accelerator program

    MUVON Therapeutics is proud to have been selected as one of 30 start-ups and projects from around the world to join Switzerlands first...
    41 views0 comments
    Greater Zurich Area features MUVON Therapeutics in article on successful biotech innovations
    Muvon
    • Apr 8, 2021
    • 1 min

    Greater Zurich Area features MUVON Therapeutics in article on successful biotech innovations

    The University of Zurich (UZH) is advancing biotechnology with innovations. Thanks to a systematic support system and the dynamic...
    77 views0 comments
    MUVON is being accelerated by Wyss Zurich
    Muvon
    • Apr 1, 2021
    • 1 min

    MUVON is being accelerated by Wyss Zurich

    MUVON Therapeutics is proud to announce the acceptance as a Wyss Zurich Project starting April 2021. The Wyss Zurich is a joint...
    90 views0 comments
    Modern Therapy of Urinary Incontinence Using Muscle Stem Cells (Article in German)
    Muvon
    • Jan 20, 2021
    • 1 min

    Modern Therapy of Urinary Incontinence Using Muscle Stem Cells (Article in German)

    Abstract: Urinary incontinence affects a large number of patients, and the cost of treatment continues to rise with the demographic...
    209 views0 comments
    The Beginning of the MUVON Story
    Muvon
    • Dec 21, 2020
    • 1 min

    The Beginning of the MUVON Story

    In October 2020 MUVON Therapeutics Ltd. was founded. The technology behind MUVON was developed over the past decade at the University of...
    76 views0 comments
    Muscle Precursor Cells for the Restoration of Irreversibly Damaged Sphincter Function
    Muvon
    • Jun 26, 2020
    • 1 min

    Muscle Precursor Cells for the Restoration of Irreversibly Damaged Sphincter Function

    Abstract Multiple modalities, including injectable bulking agents and surgery, have been used to treat stress urinary incontinence....
    111 views0 comments
    The role of donor age and gender in the success of human muscle precursor cell transplantation
    Muvon
    • Jun 25, 2020
    • 1 min

    The role of donor age and gender in the success of human muscle precursor cell transplantation

    Abstract Autologous cell transplantation for the treatment of muscle damage is envisioned to involve the application of muscle precursor...
    40 views0 comments
    muvon_therapeutics_icon.png
    LINKS
    • Home
    • Technology
    • Clinical Applications
    • About Us
    • News
    • Open Positions
    • Contact
    ABOUT

    info@muvon-therapeutics.ch

    MUVON Therapeutics AG

    c/o ETH Zürich

    Weinbergstrasse 35

    WEH G-Stock

    8092 Zürich

    Schweiz

    SOCIAL
    • White LinkedIn Icon
    • YouTube

    © 2020 by MUVON Therapeutics AG - Designed by Wyssraumdesign